当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial.
The Lancet ( IF 168.9 ) Pub Date : 2018-07-28 , DOI: 10.1016/s0140-6736(18)31553-8
Hunter B Moore , Ernest E Moore , Michael P Chapman , Kevin McVaney , Gary Bryskiewicz , Robert Blechar , Theresa Chin , Clay Cothren Burlew , Fredric Pieracci , F Bernadette West , Courtney D Fleming , Arsen Ghasabyan , James Chandler , Christopher C Silliman , Anirban Banerjee , Angela Sauaia

Plasma is integral to haemostatic resuscitation after injury, but the timing of administration remains controversial. Anticipating approval of lyophilised plasma by the US Food and Drug Administration, the US Department of Defense funded trials of prehospital plasma resuscitation. We investigated use of prehospital plasma during rapid ground rescue of patients with haemorrhagic shock before arrival at an urban level 1 trauma centre.

中文翻译:

血浆优先复苏治疗城市紧急地面运输过程中的出血性休克:一项随机试验。

血浆对受伤后的止血复苏是必不可少的,但给药时间仍存在争议。预期美国食品和药物管理局批准冻干血浆,美国国防部资助了院前血浆复苏试验。我们调查了出血性休克患者到达市区1级创伤中心之前的快速地面抢救过程中院前血浆的使用情况。
更新日期:2018-07-26
down
wechat
bug